Stereotaxis closes acquisition of Access Point Technologies, issues 1.49M shares

Stereotaxis, Inc.

Acquisition of Access Point Technologies EP, Inc. (APT) completed on July 31, 2024.
Issued 1,486,620 shares of common stock as upfront stock consideration.
APT designs and manufactures diagnostic catheters for cardiac ablation, sold globally.
Shares issued in private placement under Section 4(a)(2) and Rule 506 of Regulation D.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.